Five-year survival, quality of life, and individual costs of 303 consecutive medical intensive care patients—A cost-utility analysis - Concepedia

Concepedia

Publication | Closed Access

Five-year survival, quality of life, and individual costs of 303 consecutive medical intensive care patients—A cost-utility analysis

75

Citations

27

References

2005

Year

Jürgen Graf, Jörg Wagner, Carmen Graf, Karl‐Christian Koch, Uwe Janssens

Critical Care Medicine

Abstract

Considering the severity of illness and the patients' outcome, the costs associated with both life year and quality-adjusted life year gained were within generally accepted limits for other potentially life-saving treatments.

References

	Year	Citations
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. John E. Ware, Cathy D. Sherbourne PubMed Quality Of LifeHealth OutcomeItem Response TheoryGeriatric MedicinePrimary Care	1992	34K
The MOS 36-ltem Short-Form Health Survey (SF-36) John E. Ware, Cathy D. Sherbourne Medical Care NursingQuality Of LifePrimary CareHealth PolicyHealthy Aging	1992	29.1K
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure Jean‐Louis Vincent, Rui P. Moreno, Jukka Takala, Intensive Care Medicine Viral SepsisAcute CareSepsisSepsis PhenotypingOrgan Dysfunction/failure	1996	11.2K
A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study J. R. Le Gall JAMA	1993	6.3K
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis Gordon R. Bernard, Jean‐Louis Vincent, Pierre‐François Laterre, New England Journal of Medicine	2001	6.1K
A New Simplified Acute Physiology Score (SAPS II) Based on a European/North American Multicenter Study Jean‐Roger Le Gall JAMA Trauma ResuscitationAdult Cardiac SurgeryPhysiological StatusPrognosisPrehospital Resuscitation	1993	6K
Statistics notes: Cronbach's alpha: Table 1 J M. Bland BMJ	1997	5.2K
Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial Ferenc Folláth, H. Just, JGY Papp, The Lancet Lido StudyIntravenous LevosimendanHeart FailureCardiac AnaesthesiaCardiovascular Disease	2002	1.2K
Recommendations for Reporting Cost-effectiveness Analyses Joanna E. Siegel JAMA Cost-effectiveness AnalysisProgram ImplementationHealth Care FinanceProgram EvaluationClinical Trials	1996	1.1K
German translation and psychometric testing of the SF-36 Health Survey: Preliminary results from the IQOLA project Monika Bullinger Social Science & Medicine Quality Of LifePsychiatryHealth OutcomeLanguage TestingCross-cultural Assessment	1995	756

Page 1